Jazz Pharmaceuticals (JAZZ)

Company Ticker Sector | Industry Quality PAR
Jazz Pharmaceuticals JAZZ Healthcare | Biotechnology 92 15.9%
Current Price (03/26) $136.54
CAPS Rating (Rate this stock on CAPS) Foolcaps 3
Expected Income Statement
Current Sales 1,931.0
Sales Growth Forecast 13.6%
Net Profit Margin 41.5%
Projected Shares Outstanding 53.07
EPS - Five year Forecast $28.53
Average P/E Ratio 10.0
Projected Average Price $285.32
Price Appreciation (Annualized) 15.9%
Annual Dividend Yield 0.0%
Projected Annual Return 15.9%
Quality
Financial Strength 87 21.9
EPS Stability 87 21.8
Industry Sales Growth Rate 16.5% 10.3
Industry Net Profit Margin 29.0% 17.9
Calculated Quality Rating 71.8
Fool CAPS

Total Players

308 Outperforms
68 Underperforms
 

All-Stars (72)

57 Outperforms (79%)
15 Underperforms
 
Fundamental Data Updated: 03/08/2019

MIPAR 8.9%  
Sweet Spot 13.9% - 18.9%  

Top In Biotechnology

Ticker Quality PAR
JAZZ 92 15.9%
BIIB 81 17.8%
REGN 82 17.0%
CBPO 73 13.9%
AMGN 91 8.5%

Top In Healthcare

Ticker Quality PAR
ABBV 97 16.2%
ALGN 99 15.3%
CMD 92 16.2%
JAZZ 92 15.9%
CNC 80 19.0%